Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
d-MAPPS™ Ophthalmic Solution in Chronic Ocular Graft-Versus-Host Disease
NCT07776210Phase 3Recruiting
- Sponsor
- Regenerative Ocular Immunobiologics, LLC
- Start
- Sep 2026
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
A Phase 3 trial of d-MAPPS Ophthalmic Solution in ocular graft-versus-host disease (oGVHD), sponsored by Regenerative Ocular Immunobiologics, LLC. Started Sep 2026; status: recruiting.
02
Drugs
d-MAPPS Ophthalmic Solution
03
Conditions
ocular graft-versus-host disease (oGVHD)
Beyond the preview
Go deeper on NCT07776210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07776210.